Actinium Pharmaceuticals (ATNM) Balance Sheet: Assets & Liabilities

Actinium Pharmaceuticals (ATNM) Balance Sheet

As of Dec 31, 2025 (end of fiscal 2025), Actinium Pharmaceuticals reported total assets of $51.77M and total liabilities of $43.94M. Shareholders' equity was $7.83M, down 76.1% from $32.76M a year earlier. Total debt stood at $1.69M against $48.00M in cash and short-term investments, a net cash position of $46.30M. That puts debt-to-equity at 0.22, compared with 0.07 a year earlier.

Actinium Pharmaceuticals Balance Sheet Analysis

Values in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Actinium Pharmaceuticals, Inc. (ATNM) - Annual data in millions USD
Breakdown	FY 2025	FY 2024	FY 2023	FY 2022	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period ending	Dec 2025	Dec 2024	Dec 2023	Mar 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018	Dec 2017
Current Assets
Cash and Cash Equivalents	48.00	72.90	76.68	108.91	108.91	77.83	63.56	9.25	13.67	17.40
Cash & Short-Term Investments	48.00	72.90	76.68	108.91	108.91	77.83	63.56	9.25	13.67	17.40
Accounts Receivable	0.00	0.00	0.00	0.00	-	0.00	0.00	0.00	0.00	0.00
Inventory	0.00	0.00	0.00	0.00	-	0.00	0.00	0.00	0.00	0.00
Other Current Assets	1.38	1.60	0.23	2.03	2.03	0.06	1.32	0.83	0.66	0.44
Total Current Assets	49.38	74.51	78.26	110.94	110.94	79.75	64.93	10.09	14.33	17.84
Non-Current Assets
Property, Plant & Equipment (Net)	2.06	2.07	2.87	2.95	2.95	0.64	1.03	1.14	0.12	0.06
Long-Term Investments	0.00	0.32	0.31	0.00	-	0.00	0.39	0.39	0.05	0.05
Other Non-Current Assets	0.34	0.32	0.31	0.30	0.30	0.00	0.44	0.05	0.39	0.39
Total Non-Current Assets	2.39	2.39	3.18	3.25	3.25	0.64	1.47	1.58	0.56	0.50
Total Assets	51.78	76.90	81.45	114.19	114.19	80.39	66.40	11.67	14.89	18.34
Current Liabilities
Accounts Payable	0.00	7.57	7.95	10.13	10.13	5.54	4.34	4.60	5.81	4.65
Short-Term Debt	0.72	1.16	0.54	0.50	-	0.31	0.43	0.75	0.25	0.00
Deferred Revenue	35.00	0.00	0.00	0.00	-	1.00	0.00	-4.60	-6.06	0.00
Other Current Liabilities	-27.75	-0.58	0.00	0.00	-	1.00	0.00	4.60	0.00	0.02
Total Current Liabilities	7.97	8.15	8.49	10.63	10.63	6.84	4.77	5.34	6.06	4.67
Non-Current Liabilities
Long-Term Debt	0.97	0.99	1.57	2.08	2.08	0.00	0.31	0.68	0.01	0.00
Other Non-Current Liabilities	0.00	35.00	35.00	35.00	35.00	0.00	0.00	0.00	0.00	0.00
Total Non-Current Liabilities	35.97	35.99	36.57	37.08	37.08	0.00	0.31	0.68	0.01	0.00
Total Liabilities	43.94	44.14	45.07	47.71	47.71	6.84	5.08	6.03	6.08	4.67
Stockholders' Equity
Common Stock	0.03	0.03	0.03	0.03	0.03	0.02	0.02	0.16	0.12	0.08
Retained Earnings	-409.71	-375.83	-337.58	-288.77	-288.77	-255.75	-230.97	-208.76	-186.86	-163.15
Accumulated Other Comprehensive Income	-0.02	0.00	0.00	0.00	-	-	0.00	0.00	-0.27	-0.22
Additional Paid-in Capital	417.54	408.55	373.93	355.22	355.22	329.27	292.28	214.24	195.55	176.74
Shares Outstanding	31.20	31.20	27.63	-	25.67	22.14	-	-	-	-
Total Stockholders' Equity	7.83	32.76	36.38	66.48	66.48	73.55	61.32	5.64	8.81	13.67
Total Liabilities & Equity	51.78	76.90	81.45	114.19	114.19	80.39	66.40	11.67	14.89	18.34

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Actinium Pharmaceuticals Balance Sheet

How much debt does Actinium Pharmaceuticals have?

Actinium Pharmaceuticals had total debt of $1.69M as of Dec 31, 2025, against $48.00M in cash and short-term investments. Its debt-to-equity ratio was 0.22. Total debt was $2.15M a year earlier.

What are Actinium Pharmaceuticals's total assets?

Actinium Pharmaceuticals reported total assets of $51.77M as of Dec 31, 2025, down 32.7% from $76.90M a year earlier. Total liabilities were $43.94M.

What is Actinium Pharmaceuticals's shareholders' equity?

Actinium Pharmaceuticals's shareholders' equity was $7.83M as of Dec 31, 2025, or about $0.25 of book value per share.

What is the debt-to-equity ratio?

The debt-to-equity ratio divides a company's total debt by its shareholders' equity. It shows how much of the business is financed with borrowed money; normal levels vary widely by industry. Full definition